hapabapa Lucid Group (NASDAQ:LCID) is on watch after a new recall of vehicles was announced by the National Highway Traffic Safety Administration. The electric vehicle will recall about 5,251 of its 2022-2023 Air luxury sedans due to a software error that could cause a loss of power and about 7,506Continue Reading
Ole Schwander Castle Biosciences (NASDAQ:CSTL) traded lower on Friday after a local Medicare Administrative Contractor (MAC) updated its coverage policy, finalizing a proposal not to reimburse the company’s DecisionDx-SCC cancer test. On Thursday, Palmetto GBA, a MAC for Medicare’s Molecular Diagnostics Services program (MolDX), finalized and maintained a non-coverage decisionContinue Reading
Andrii Dodonov Update 2.00PM EST: Adds latest share move and Oppenheimer’s downgrade Cell therapy developer Cartesian Therapeutics (NASDAQ:RNAC) announced Tuesday that its lead asset, Descartes-08, reached the main goal in a mid-stage trial against the muscle disorder myasthenia gravis (MG). In conjunction with the data, the Gaithersburg, Maryland-based biotech announcedContinue Reading
Andree_Nery/iStock via Getty Images Shoals Technologies (NASDAQ:SHLS) -2.9% in Tuesday’s trading after Citigroup double downgrades the solar energy equipment supplier to Sell from Buy with a $5 price target, ahead of an initial determination of its patent infringement case against Voltage. Shoals’ (SHLS) infringement case has an initial determination slatedContinue Reading
hapabapa Hubspot (NYSE:HUBS) was in focus on Friday after several news outlets reported that the marketing software company had been impacted by a cybersecurity incident. Shares slipped around 0.3% in mid-afternoon trading. Hubspot, based in Cambridge, Mass., did not immediately respond to a request for comment from Seeking Alpha aboutContinue Reading
MicroStockHub X4 Pharmaceuticals (NASDAQ:XFOR) traded sharply lower on Thursday after the biotech updated data from an ongoing Phase 2 trial for its lead candidate mavorixafor in chronic neutropenia (CN), a rare blood disorder. Citing a May 24 data cut, the Boston, Massachusetts-based biotech said mavorixafor, which X4 (XFOR) markets asContinue Reading
Spencer Platt/Getty Images News U.S. stocks on Tuesday were mixed, with losses in major retailers countering a rebound in Nvidia (NVDA). The chip giant’s pullback from correction territory helped the benchmark S&P 500 (SP500) and the tech-heavy Nasdaq Composite (COMP:IND) halt a three-day slide each. The Nasdaq (COMP:IND) advanced 1.10%Continue Reading
hapabapa Micron (NASDAQ:MU) slipped on Monday, even as investment firm Hedgeye added the memory chipmaker as a new long idea ahead of its earnings report later this week. Micron’s guidance should top estimates amid strong pricing for artificial intelligence driven products (HBM3E, DDR5 and eSSD) along with some of itsContinue Reading
